Back to List View Graph View

Cuproptosis

Cuproptosis is a form of regulated cell death driven by intracellular copper accumulation acting on the mitochondria.

Where the papers sit

14 papers from the last 6 months study cuproptosis directly · updated from PubMed 10 Nov 2026

Study type 0 clinical trials · 1 human data · 12 preclinical · 1 unclassified

Themes 3 themes

  • Cuproptosis and Cancer Immunity

    Cuproptosis is being paired with radiotherapy, sunitinib, and immunotherapy to overcome resistant tumors. Copper nanoparticles, hydrogels, nanocapsules, and bioorthogonal systems aim to amplify tumor killing while reshaping the tumor microenvironment. Immunogenic cell death and damage-associated molecular patterns recur as links to stronger antitumor immunity. Mitochondrial energy metabolism remains a key determinant of response, especially in thyroid, renal, and triple-negative breast cancers.

    8 papers · 57.1%

  • Copper Homeostasis and Cell Injury

    Copper homeostasis and mitochondrial oxidative stress connect cuproptosis-related injury across neural, cardiac, and lung cancer settings. SLC31A1 and FDX1 recur as mechanistic nodes linking copper transport to mitochondrial damage. Luteolin is explored as protection against doxorubicin cardiotoxicity, whereas FOSL1-mediated signaling is targeted to sensitize radioresistant non-small cell lung cancer. The shared biology is clearer than any single therapeutic direction.

    3 papers · 21.4%

  • Photothermal Cuproptosis Therapy

    Multimodal nanotherapies are combining cuproptosis with photothermal treatment or disulfidptosis rather than relying on copper toxicity alone. Hyaluronic acid-coated silica nanoparticles target lung tumors, while photothermal nanomachines seek controlled activation in tumor cells. Oxygen-pump microneedles extend the strategy to melanoma and immunotherapy. The central aim is coordinated redox and heat stress that improves tumor killing and immune response.

    3 papers · 21.4%

Papers

The 14 papers from the last 6 months that study cuproptosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Cuproptosis and Cancer Immunity (8)
  1. Cuproptosis enters the cancer-immunity circuit. Cell · 20 Aug 2026 PMID 42624074
  2. A Self-Reinforcing Cuproptosis-Radiotherapy Loop by Copper Carbonate Nanoparticles for Enhanced Immunotherapy. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587511
  3. Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer. Nano letters · 12 Aug 2026 PMID 42584274
  4. A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
  5. Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
  6. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
  7. Deciphering the interplay between cuproptosis and mitochondrial energy metabolism in thyroid cancer: a multi-omics study for molecular subtyping, prognosis, and tumor microenvironment characterization. Molecular and cellular biochemistry · 19 Jun 2026 PMID 42319714
  8. A sonopiezoresponsive covalent organic framework-based smart nanoreactor orchestrates in situ bioorthogonal chemistry and cuproptosis for enhanced tumor therapy. Acta biomaterialia · 13 Jun 2026 PMID 42288303
Copper Homeostasis and Cell Injury (3)
  1. Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. PloS one · 24 Aug 2026 PMID 42636217
  2. Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
  3. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
Photothermal Cuproptosis Therapy (3)
  1. Oxygen pump microneedles coupling cuproptosis and disulfidptosis to enhance melanoma immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 21 Sept 2026 PMID 42767378
  2. Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
  3. Hyaluronic acid-camouflaged dendritic silica nanoparticles enable targeted cuproptosis and photothermal therapy for lung cancer. Colloids and surfaces. B, Biointerfaces · 5 Jun 2026 PMID 42247956

By study type

Human data, design not indexed (1)
  1. Photothermal Pulse Output-Nanomachines for Enhanced Cuproptosis in Tumor Cells. ACS applied bio materials · 30 Jun 2026 PMID 42378513
Preclinical: animal, cell and lab studies (12)
  1. Oxygen pump microneedles coupling cuproptosis and disulfidptosis to enhance melanoma immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 21 Sept 2026 PMID 42767378
  2. Tanshinone IIA attenuates cognitive impairment in vascular dementia rats by modulating copper homeostasis via the SLC31A1/FDX1 axis. PloS one · 24 Aug 2026 PMID 42636217
  3. Cuproptosis enters the cancer-immunity circuit. Cell · 20 Aug 2026 PMID 42624074
  4. Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer. ACS nano · 18 Aug 2026 PMID 42611215
  5. A Self-Reinforcing Cuproptosis-Radiotherapy Loop by Copper Carbonate Nanoparticles for Enhanced Immunotherapy. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587511
  6. Brachytherapy Combined with Cuproptosis-Inducing Radiosensitizer Overcomes Radioresistance in Triple-Negative Breast Cancer. Nano letters · 12 Aug 2026 PMID 42584274
  7. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
  8. A Self-Monitoring Single-Atom Copper Nanocapsule for Cascade-Responsive Tumor Cuproptosis Therapy. Angewandte Chemie (International ed. in English) · 6 Jul 2026 PMID 42405495
  9. Injectable pH-responsive gelatin methacryloyl hydrogel for cuproptosis-synergized sunitinib therapy and immune reprogramming in clear cell renal cell carcinoma. Acta biomaterialia · 2 Jul 2026 PMID 42392517
  10. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
  11. A sonopiezoresponsive covalent organic framework-based smart nanoreactor orchestrates in situ bioorthogonal chemistry and cuproptosis for enhanced tumor therapy. Acta biomaterialia · 13 Jun 2026 PMID 42288303
  12. Hyaluronic acid-camouflaged dendritic silica nanoparticles enable targeted cuproptosis and photothermal therapy for lung cancer. Colloids and surfaces. B, Biointerfaces · 5 Jun 2026 PMID 42247956
Unclassified: not yet indexed with MeSH (1)
  1. Deciphering the interplay between cuproptosis and mitochondrial energy metabolism in thyroid cancer: a multi-omics study for molecular subtyping, prognosis, and tumor microenvironment characterization. Molecular and cellular biochemistry · 19 Jun 2026 PMID 42319714